Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
Saved in:
| Title: | Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program. |
|---|---|
| Authors: | Loopik DL; Department of Obstetrics and Gynaecology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: diedeloopik@hotmail.com., Koenjer LM; Department of Obstetrics and Gynaecology, Radboud University Medical Center, Nijmegen, the Netherlands., Siebers AG; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands; PALGA Foundation, Houten, the Netherlands., Melchers WJG; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands., Bekkers RLM; Department of Obstetrics and Gynaecology, Catharina Hospital, Eindhoven, the Netherlands; Department of Obstetrics and Gynaecology, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands. |
| Source: | American journal of obstetrics and gynecology [Am J Obstet Gynecol] 2021 Feb; Vol. 224 (2), pp. 200.e1-200.e9. Date of Electronic Publication: 2020 Aug 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 0370476 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6868 (Electronic) Linking ISSN: 00029378 NLM ISO Abbreviation: Am J Obstet Gynecol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
